Overview: Hepatitis B e Antibody TestIntroduction: The Hepatitis B e Antibody Test detects antibodies to hepatitis B e antigen to monitor infection status, preventing liver complications. Following 2023 AASLD guidelines, it uses an immunoassay for high sensitivity, aiding in infectious disease screening. This test is critical for guiding antiviral therapy, assessing disease progression, and improving outcomes in serology for patients with chronic hepatitis B.
Other Names: Anti-HBe Assay, Hepatitis B e Antibody Test.
FDA Status: FDA-cleared diagnostic test, meeting serology standards for diagnostic accuracy.
Historical Milestone: Anti-HBe testing began in the 1970s with HBV research. Immunoassays improved in the 1980s, enhancing infection status monitoring.
Purpose: Monitors hepatitis B infection status, guides antiviral therapy, and detects anti-HBe in patients to prevent liver complications.
Test Parameters: 1. Hepatitis B e Antibody
Pretest Condition: No fasting required. Collect serum at any time. Report history of hepatitis B, treatment status, or symptoms like fatigue, and list medications.
Specimen: 2-5 mL serum (SST). Centrifuge within 1 hour. Transport in a biohazard bag within 8 hours.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document fatigue, liver pain, or history of chronic hepatitis B. Include current medications, especially antivirals, and treatment history.
Consent: Written consent required, detailing the tests purpose, monitoring implications, and potential need for treatment adjustments.
Procedural Considerations: Uses an immunoassay to detect anti-HBe antibodies. Results are available in 1-2 days, enabling rapid clinical decisions.
Factors Affecting Result Accuracy: Improper sample handling or antiviral therapy can affect results. Early infection may yield false negatives.
Clinical Significance: Positive anti-HBe indicates low viral replication, suggesting favorable disease status or treatment response. Negative results may indicate active replication.
Specialist Consultation: Consult a hepatologist for result interpretation and antiviral therapy planning.
Additional Supporting Tests: HBeAg, HBV DNA, or liver function tests to monitor hepatitis B status.
Test Limitations: Anti-HBe alone cannot fully assess disease status. Clinical correlation and additional testing are needed.
References: AASLD Hepatitis B Guidelines, 2023; Hepatology, Lok AS, 2022.
